In the present study, we evaluated the efficacy of a G-protein-coupled receptor 43 agonist against gut inflammation induced by AIEC pathobiont infection in a mouse model and showed that the GPR43 receptor agonist significantly decreased the severity of colitis in the presence of AIEC pathobionts in the gut. Here, FFAR2 is linked to colitis.